|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
|
GB9324807D0
(en)
|
1993-12-03 |
1994-01-19 |
Cancer Res Campaign Tech |
Tumour antibody
|
|
AU702250B2
(en)
|
1994-07-11 |
1999-02-18 |
Board Of Regents, The University Of Texas System |
Methods and compositions for the specific coagulation of vasculature
|
|
US6117980A
(en)
|
1997-02-21 |
2000-09-12 |
Genentech, Inc. |
Humanized anti-IL-8 monoclonal antibodies
|
|
US20030109680A1
(en)
|
2001-11-21 |
2003-06-12 |
Sunol Molecular Corporation |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
US20060235209A9
(en)
|
1997-03-10 |
2006-10-19 |
Jin-An Jiao |
Use of anti-tissue factor antibodies for treating thromboses
|
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
ＴＧＦ−βＩＩ型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
|
AU2270101A
(en)
|
1999-12-20 |
2001-07-03 |
Merck & Co., Inc. |
Pharmaceutical kit
|
|
ATE333900T1
(de)
|
2000-02-24 |
2006-08-15 |
Philogen Spa |
Zusamensetzungen und verfahren zur behandlung von angiogenese in pathologischen schädigungen
|
|
AU2001259215A1
(en)
|
2000-04-28 |
2001-11-12 |
La Jolla Institute For Allergy And Immunology |
Human anti-cd40 antibodies and methods of making and using same
|
|
PT1355919E
(pt)
|
2000-12-12 |
2011-03-02 |
Medimmune Llc |
Moléculas com semivida longa, composições que as contêm e suas utilizações
|
|
ES2353273T3
(es)
|
2000-12-26 |
2011-02-28 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anticuerpos anti-cd28.
|
|
US20040204481A1
(en)
|
2001-04-12 |
2004-10-14 |
Pnina Fishman |
Activation of natural killer cells by adenosine A3 receptor agonists
|
|
US7371371B2
(en)
|
2001-08-13 |
2008-05-13 |
University Of Southern California |
Interleukin-2 mutants with reduced toxicity
|
|
TWI338009B
(en)
|
2001-10-29 |
2011-03-01 |
Genentech Inc |
Antibodies for inhibiting blood coagulation and methods of use thereof
|
|
WO2003104425A2
(en)
|
2002-06-07 |
2003-12-18 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Novel stable anti-cd22 antibodies
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
EP2357009A1
(en)
|
2002-07-15 |
2011-08-17 |
Board of Regents, The University of Texas System |
Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
|
|
JP4463104B2
(ja)
|
2002-08-30 |
2010-05-12 |
財団法人化学及血清療法研究所 |
ヒト抗ヒトインターロイキン−６抗体及び該抗体フラグメント
|
|
EP1400534B1
(en)
|
2002-09-10 |
2015-10-28 |
Affimed GmbH |
Human CD3-specific antibody with immunosuppressive properties
|
|
CN1753912B
(zh)
|
2002-12-23 |
2011-11-02 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
US7563869B2
(en)
|
2003-01-23 |
2009-07-21 |
Ono Pharmaceutical Co., Ltd. |
Substance specific to human PD-1
|
|
WO2004076488A1
(en)
|
2003-02-27 |
2004-09-10 |
Theravision Gmbh |
A molecule which binds cd80 and cd86
|
|
KR20060015482A
(ko)
|
2003-03-21 |
2006-02-17 |
와이어쓰 |
인터루킨-21/인터루킨-21 수용체의 작용제를 이용한면역장애의 치료
|
|
JP4638876B2
(ja)
|
2003-05-23 |
2011-02-23 |
ワイス |
Ｇｉｔｒリガンド及びｇｉｔｒリガンド関連分子及び抗体及びその使用
|
|
US9005613B2
(en)
|
2003-06-16 |
2015-04-14 |
Immunomedics, Inc. |
Anti-mucin antibodies for early detection and treatment of pancreatic cancer
|
|
JP2005124568A
(ja)
|
2003-10-01 |
2005-05-19 |
Junichi Masuyama |
細胞活性化方法及びこれを用いる細胞製造方法並びに医薬組成物
|
|
NZ549040A
(en)
|
2004-02-17 |
2009-07-31 |
Schering Corp |
Use for interleukin-33 (IL33) and the IL-33 receptor complex
|
|
ES2375481T3
(es)
|
2004-03-30 |
2012-03-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticuerpos biespecíficos para elegir como diana células que participan en reacciones de tipo alérgico, composiciones y usos de los mismos.
|
|
WO2006086469A2
(en)
|
2005-02-08 |
2006-08-17 |
Genzyme Corporation |
Antibodies to tgfbeta
|
|
US7393833B2
(en)
|
2005-03-09 |
2008-07-01 |
The Board Of Regents Of The University Of Oklahoma |
Chimeric proteins with phosphatidylserine binding domains
|
|
AU2006224313B2
(en)
|
2005-03-17 |
2011-08-11 |
Ucl Biomedica Plc |
Method for actvating Natural Killer cells by tumor cell preparation in vitro
|
|
CN100509849C
(zh)
|
2005-04-07 |
2009-07-08 |
苏州大学 |
可溶性人cd28分子检测试剂盒及其应用
|
|
CN101203241B
(zh)
|
2005-04-19 |
2012-02-22 |
西雅图基因公司 |
人源化抗-cd70结合物和其应用
|
|
CA2763671A1
(en)
|
2005-04-26 |
2006-11-02 |
Pfizer Inc. |
P-cadherin antibodies
|
|
ATE459648T1
(de)
|
2005-05-11 |
2010-03-15 |
Philogen Spa |
Fusionsprotein von antikörper l19 gegen fibronectin ed-b und interleukin 12
|
|
GB0510790D0
(en)
|
2005-05-26 |
2005-06-29 |
Syngenta Crop Protection Ag |
Anti-CD16 binding molecules
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
EP1777294A1
(en)
|
2005-10-20 |
2007-04-25 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
WO2009120922A2
(en)
|
2008-03-27 |
2009-10-01 |
Zymogenetics, Inc. |
Compositions and methods for inhibiting pdgfrbeta and vegf-a
|
|
LT3216803T
(lt)
|
2008-06-25 |
2020-06-10 |
Novartis Ag |
Stabilūs ir tirpūs antikūnai, slopinantys vegf
|
|
NZ603698A
(en)
|
2008-07-08 |
2014-03-28 |
Abbvie Inc |
Prostaglandin e2 dual variable domain immunoglobulins and uses thereof
|
|
US9273136B2
(en)
|
2008-08-04 |
2016-03-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fully human anti-human NKG2D monoclonal antibodies
|
|
US8298533B2
(en)
|
2008-11-07 |
2012-10-30 |
Medimmune Limited |
Antibodies to IL-1R1
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
KR20120060877A
(ko)
|
2009-09-01 |
2012-06-12 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
|
DE102009045006A1
(de)
|
2009-09-25 |
2011-04-14 |
Technische Universität Dresden |
Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen
|
|
AU2010306677B2
(en)
|
2009-10-15 |
2013-05-23 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
WO2011100538A1
(en)
|
2010-02-11 |
2011-08-18 |
Alexion Pharmaceuticals, Inc. |
Therapeutic methods using an ti-cd200 antibodies
|
|
WO2011127324A2
(en)
|
2010-04-08 |
2011-10-13 |
JN Biosciences, LLC |
Antibodies to cd122
|
|
WO2011155607A1
(ja)
|
2010-06-11 |
2011-12-15 |
協和発酵キリン株式会社 |
抗ｔｉｍ－３抗体
|
|
US8735546B2
(en)
|
2010-08-03 |
2014-05-27 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
JP2012034668A
(ja)
|
2010-08-12 |
2012-02-23 |
Tohoku Univ |
ヒト型化抗ｅｇｆｒ抗体リジン置換可変領域断片及びその利用
|
|
CN107880136B
(zh)
|
2010-09-21 |
2021-11-12 |
阿尔托生物科学有限公司 |
多聚体il-15可溶性融合分子与其制造与使用方法
|
|
WO2012051147A1
(en)
|
2010-10-11 |
2012-04-19 |
Abbott Laboratories |
Processes for purification of proteins
|
|
CN102153653B
(zh)
|
2010-12-30 |
2012-08-15 |
厦门大学 |
肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法
|
|
GB201103955D0
(en)
|
2011-03-09 |
2011-04-20 |
Antitope Ltd |
Antibodies
|
|
CN105884900A
(zh)
|
2011-04-19 |
2016-08-24 |
梅里麦克制药股份有限公司 |
单特异性和双特异性抗igf-1r和抗erbb3抗体
|
|
SMT201800269T1
(it)
|
2011-04-25 |
2018-07-17 |
Daiichi Sankyo Co Ltd |
Anticorpo anti-b7-h3
|
|
SG10201603962TA
(en)
|
2011-05-25 |
2016-07-28 |
Innate Pharma Sa |
Anti-kir antibodies for the treatment of inflammatory disorders
|
|
US8753640B2
(en)
|
2011-05-31 |
2014-06-17 |
University Of Washington Through Its Center For Commercialization |
MIC-binding antibodies and methods of use thereof
|
|
SG195253A1
(en)
|
2011-06-03 |
2013-12-30 |
Xoma Technology Ltd |
Antibodies specific for tgf-beta
|
|
WO2012170470A1
(en)
|
2011-06-06 |
2012-12-13 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for detection and treatment of cancer
|
|
CN103747803B
(zh)
|
2011-06-22 |
2016-10-12 |
国家医疗保健研究所 |
抗axl抗体及其用途
|
|
EP2537933A1
(en)
|
2011-06-24 |
2012-12-26 |
Institut National de la Santé et de la Recherche Médicale (INSERM) |
An IL-15 and IL-15Ralpha sushi domain based immunocytokines
|
|
AU2012335205A1
(en)
|
2011-11-11 |
2014-05-29 |
Rinat Neuroscience Corp. |
Antibodies specific for Trop-2 and their uses
|
|
EP4372084A3
(en)
|
2012-01-26 |
2024-08-14 |
Tecan Genomics, Inc. |
Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
|
|
US10259626B2
(en)
|
2012-03-08 |
2019-04-16 |
Selig Sealing Products, Inc. |
Container sealing member with protected security component and removal tab
|
|
KR101535341B1
(ko)
|
2012-07-02 |
2015-07-13 |
한화케미칼 주식회사 |
Dll4에 특이적으로 결합하는 신규한 단일클론항체 및 이의 용도
|
|
CA2876285A1
(en)
|
2012-08-08 |
2014-02-13 |
Roche Glycart Ag |
Interleukin-10 fusion proteins and uses thereof
|
|
US20150218280A1
(en)
|
2012-08-10 |
2015-08-06 |
University Of Southern California |
CD20 scFv-ELPs METHODS AND THERAPEUTICS
|
|
AU2013302696B9
(en)
|
2012-08-14 |
2018-08-09 |
Ibc Pharmaceuticals, Inc. |
T-cell redirecting bispecific antibodies for treatment of disease
|
|
WO2014033130A1
(en)
|
2012-08-28 |
2014-03-06 |
Institut Curie |
Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
|
|
HUE033369T2
(en)
|
2012-11-20 |
2017-11-28 |
Sanofi Sa |
Anti-ceacam5 antibodies and uses thereof
|
|
WO2014095808A1
(en)
|
2012-12-17 |
2014-06-26 |
Delenex Therapeutics Ag |
Antibodies against il-1 beta
|
|
EP2948475A2
(en)
|
2013-01-23 |
2015-12-02 |
AbbVie Inc. |
Methods and compositions for modulating an immune response
|
|
TW201446794A
(zh)
|
2013-02-20 |
2014-12-16 |
Novartis Ag |
利用抗－ｃｄ１２３嵌合抗原受體工程化ｔ細胞之初級人類白血病有效靶向
|
|
WO2014159531A1
(en)
|
2013-03-14 |
2014-10-02 |
The Board Of Regents Of The University Of Texas System |
Monoclonal antibodies targeting epcam for detection of prostate cancer lymph node metastases
|
|
AU2014268364A1
(en)
|
2013-05-24 |
2015-12-10 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
JP2015030666A
(ja)
*
|
2013-07-31 |
2015-02-16 |
学校法人順天堂 |
抗ヒトｃｄ２６モノクローナル抗体又はその抗原結合性断片
|
|
JP2015054824A
(ja)
|
2013-09-10 |
2015-03-23 |
学校法人順天堂 |
Ｍｅｒｓコロナウイルス感染症予防治療剤
|
|
CN103709251B
(zh)
|
2013-12-19 |
2016-04-13 |
江苏众红生物工程创药研究院有限公司 |
全人源抗cd26抗体及其应用
|
|
KR102127408B1
(ko)
|
2014-01-29 |
2020-06-29 |
삼성전자주식회사 |
항 Her3 scFv 단편 및 이를 포함하는 항 c-Met/항 Her3 이중 특이 항체
|
|
EP3099717B1
(en)
|
2014-01-31 |
2019-03-27 |
Novartis AG |
Antibody molecules to tim-3 and uses thereof
|
|
CA2937034A1
(en)
|
2014-02-03 |
2015-08-06 |
Riken |
Anti-tissue factor monoclonal antibody
|
|
FR3021970B1
(fr)
|
2014-06-06 |
2018-01-26 |
Universite Sciences Technologies Lille |
Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
|
|
AU2015305754B2
(en)
|
2014-08-19 |
2018-10-25 |
Merck Sharp & Dohme Llc |
Anti-tigit antibodies
|
|
MY193723A
(en)
|
2014-08-29 |
2022-10-27 |
Hoffmann La Roche |
Combination therapy of tumor-targeted il-2 variant immunocytokines and antibodies against human pd-l1
|
|
JP7211703B2
(ja)
|
2014-12-22 |
2023-01-24 |
ザ ロックフェラー ユニバーシティー |
抗ｍｅｒｔｋアゴニスト抗体及びその使用
|
|
US10744157B2
(en)
|
2015-03-26 |
2020-08-18 |
The Trustees Of Dartmouth College |
Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of using
|
|
KR20170138494A
(ko)
|
2015-04-17 |
2017-12-15 |
엘살리스 비오떼끄 |
항-ｔｙｒ０３ 항체 및 이의 용도
|
|
KR101778439B1
(ko)
|
2015-04-27 |
2017-09-14 |
울산대학교 산학협력단 |
자연살해세포 활성화제를 유효성분으로 함유하는 면역증강 및 항암활성증진용 조성물
|
|
US10723793B2
(en)
|
2015-06-12 |
2020-07-28 |
Ludwig Institute For Cancer Research, Ltd. |
TGF-β3 specific antibodies and methods and uses thereof
|
|
PT3328894T
(pt)
|
2015-08-06 |
2019-02-13 |
Agency Science Tech & Res |
Anticorpos de cadeia comum gama/il2rbeta
|
|
KR20180061226A
(ko)
|
2015-09-11 |
2018-06-07 |
와이즈에이씨가부시키가이샤 |
항cd26 항체와 다른 항암제를 조합한 암 치료용 조성물
|
|
CA2994858C
(en)
|
2015-09-25 |
2024-01-23 |
Genentech, Inc. |
Anti-tigit antibodies and methods of use
|
|
CN108367071B
(zh)
|
2015-11-13 |
2022-05-13 |
达纳-法伯癌症研究所有限公司 |
用于癌症免疫疗法的nkg2d-ig融合蛋白
|
|
JP2019511911A
(ja)
|
2016-02-17 |
2019-05-09 |
ノバルティス アーゲー |
Ｔｇｆベータ２抗体
|
|
MX2018010445A
(es)
|
2016-03-01 |
2019-10-17 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Anticuerpos especificos del receptor de poliovirus humano (rvp).
|
|
WO2017189526A1
(en)
|
2016-04-25 |
2017-11-02 |
Musc Foundation For Research Development |
Activated cd26-high immune cells and cd26-negative immune cells and uses thereof
|
|
ES3014658T3
(en)
|
2016-10-05 |
2025-04-23 |
Univ Central Florida Res Found Inc |
Methods and compositions related to nk cell and anti-pdl1 cancer therapies
|
|
CN118562016A
(zh)
|
2016-10-21 |
2024-08-30 |
艾尔特生物科技公司 |
基于多聚体il-15的分子
|
|
MX2019007981A
(es)
|
2017-01-03 |
2019-10-15 |
Bioatla Llc |
Terapeutica de proteinas para el tratamiento de celulas senescentes.
|
|
TW202506185A
(zh)
|
2017-01-20 |
2025-02-16 |
法商賽諾菲公司 |
抗TGF-β抗體及其用途
|
|
CN110461357A
(zh)
|
2017-02-28 |
2019-11-15 |
阿菲姆德股份有限公司 |
抗cd16a抗体与细胞因子的组合
|
|
CN117986384A
(zh)
|
2017-03-06 |
2024-05-07 |
艾尔特生物科技公司 |
与il-12和il-18的基于il-15的融合物
|
|
EP3601538A4
(en)
|
2017-03-27 |
2021-03-10 |
Nantcell, Inc. |
ANK AND IL-12 COMPOSITIONS AND METHODS
|
|
EP3421607A1
(en)
|
2017-06-29 |
2019-01-02 |
Fundación Centro Nacional de Investigaciones Oncológicas Carlos III |
Identification and elimination of damaged and/or senescent cells
|
|
EP3676289B1
(en)
|
2017-08-28 |
2026-03-04 |
Altor BioScience, LLC |
Il-15-based fusions to il-7 and il-21
|
|
US11518792B2
(en)
|
2018-08-30 |
2022-12-06 |
HCW Biologics, Inc. |
Multi-chain chimeric polypeptides and uses thereof
|
|
CA3109361A1
(en)
|
2018-08-30 |
2020-03-05 |
HCW Biologics, Inc. |
Single-chain and multi-chain chimeric polypeptides and uses thereof
|
|
US11401324B2
(en)
|
2018-08-30 |
2022-08-02 |
HCW Biologics, Inc. |
Single-chain chimeric polypeptides and uses thereof
|
|
CN120924491A
(zh)
|
2019-06-21 |
2025-11-11 |
免疫生物公司 |
多链嵌合多肽和其用途
|
|
AU2021220870A1
(en)
|
2020-02-11 |
2022-08-04 |
Immunitybio, Inc. |
Methods of treating age-related and inflammatory diseases
|
|
WO2021163299A1
(en)
|
2020-02-11 |
2021-08-19 |
HCW Biologics, Inc. |
Chromatography resin and uses thereof
|
|
CA3169243A1
(en)
|
2020-02-11 |
2021-08-19 |
HCW Biologics, Inc. |
Methods of activating regulatory t cells
|
|
US12024545B2
(en)
|
2020-06-01 |
2024-07-02 |
HCW Biologics, Inc. |
Methods of treating aging-related disorders
|
|
WO2023201311A1
(en)
|
2022-04-13 |
2023-10-19 |
HCW Biologics, Inc. |
Multi-chain chimeric polypeptide for use in the treatment of treating neuroinflammatory disorder
|